Tips for cancer

This Viewpoint considers why fragmentation occurs and suggests a potential path forward for developing evidenced-based strategies that can reduce the occurrence of fragmentation and its associated harms. from JAMA Internal Medicine Online First https://ift.tt/yOo5BA4

This cohort study investigates the number and characteristics of US mental health specialists who had shifted to a fully virtual practice as of 2022. from JAMA Health Forum New Online https://ift.tt/z1W7GIp

This cohort study uses US Census data to examine changes in job flow rates into and out of the health care sector before and after the COVID-19 pandemic. from JAMA Health Forum New Online https://ift.tt/Xv7ZD0u

This cross-sectional study assesses utilization of COVID-19 outpatient treatment in the Medicare population and simulates the potential outcome of allocating treatment according to patient risk for severe COVID-19. from JAMA Health Forum New Online https://ift.tt/9YiZWLA

This Viewpoint describes the implications of US v Rahimi for public health and safety of persons experiencing domestic violence. from JAMA Health Forum New Online https://ift.tt/HSrlT0P

This JAMA Forum discusses 3 health policy concepts (policy humility, radical compassion, and reasoned reform) to help decision-makers during this period of increased political division in the US. from JAMA Health Forum New Online https://ift.tt/1KWcBJM

The US Supreme Court’s decision in the Dobbs v Jackson Women’s Health Organization case allows individual states to determine access to abortion. Since the decision, 14 states have prohibited abortion at any gestational age. from JAMA Internal Medicine Online First https://ift.tt/rx5OusT

This cross-sectional study estimates the incidence of rape-related pregnancies in US states with abortion bans. from JAMA Internal Medicine Online First https://ift.tt/uNeL6fG

National practice groups and decades of research strongly support treating opioid use disorder (OUD) as a chronic illness and specifically call for the use of evidence-based medications to treat OUD throughout pregnancy and beyond. The criterion-standard medications for OUD (MOUD), including during pregnancy, are buprenorphine (approved by the US Food and Drug Administration in 2002) and methadone (approved by the US Food and Drug Administration to treat OUD in 1972). While evidence suggests that pregnancy may represent a specific window of opportunity to engage individuals in MOUD and that MOUD leads to better outcomes for the maternal-infant dyad, fewer than 1 in 4 individuals with OUD receive treatment in any given month of pregnancy. from JAMA Internal Medicine Online First https://ift.tt/O24WuiF

This cohort study compares the risk of congenital malformations among infants following in utero exposure to buprenorphine vs methadone. from JAMA Internal Medicine Online First https://ift.tt/zW4e8dc

This Viewpoint discusses the traditional goals of health insurance and contrasts those with the current needs of insurance beneficiaries. from JAMA Internal Medicine Online First https://ift.tt/5NUz8ip

This Viewpoint describes issues with cost sharing for health care costs and suggests improvements to current cost sharing systems. from JAMA Internal Medicine Online First https://ift.tt/9Gyu7LI

This Viewpoint reviews the advantages and limitations of virtual doula services and discusses their potential to address the maternal health crisis. from JAMA Health Forum New Online https://ift.tt/fh3lPEK

This JAMA Forum discusses the implications for patient care by recognizing climate change as a social determinant of health. from JAMA Health Forum New Online https://ift.tt/AdZeVtW

This cohort study examines the whether there were changes in opioid prescribing and opioid-related health outcomes after implementation of British Columbia’s Safer Opioid Supply policy. from JAMA Internal Medicine Online First https://ift.tt/0lftdDa

This cross-sectional study examines the association of dental, vision, and hearing supplemental benefits offered in Medicare Advantage plans with plan choices of traditionally underserved Medicare beneficiaries. from JAMA Health Forum New Online https://ift.tt/8P6jD7q

This Viewpoint discusses the importance of the Drug Supply Chain Security Act and the need for pharmaceutical supply chain safeguards. from JAMA Health Forum New Online https://ift.tt/1IUVcZf

This JAMA Forum discusses declining time and space for appreciation of what has been accomplished in clinical medicine and health policy. from JAMA Health Forum New Online https://ift.tt/BzPet9N

This Viewpoint examines the similarities between medical errors and COVID-19 and discusses lessons applicable to ongoing and emerging health challenges. from JAMA Internal Medicine Online First https://ift.tt/7HJ2zoW

Health Policy from JAMA Health Forum New Online https://ift.tt/TuW2kiY

To the Editor In a recent meta-analysis, Bretthauer et al addressed the question of whether and to what extent the established cancer screening approaches prolong lives. Their study suggests that claims that screening saves lives are not substantiated by the current best available evidence. However, the methods used by the authors are inadequate and the results are misleading for multiple reasons. from JAMA Internal Medicine Online First https://ift.tt/vPI1lHo

In Reply The starting point for our study was the promotion of cancer screening as lifesaving—a powerful claim. However, our study findings showed that this statement is not backed by trial evidence. As we stated in the conclusion of our meta-analysis, we do not advocate for abandoning all screening; rather, we find it important to call for moderation and fact-based information instead of promising a longer life with cancer screening. from JAMA Internal Medicine Online First https://ift.tt/Kl6h7VY